Giovannoni G, et al. Cladribine tablets in high disease activity (HDA) subgroups from the CLARITY study of patients with relapsing multiple sclerosis (RMS). EP1157. EAN 2017.
CVA-patiënt kampt jaren later nog met veel klachten
dec 2018 | Neuro-vasculair